JPWO2022006283A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022006283A5 JPWO2022006283A5 JP2022581408A JP2022581408A JPWO2022006283A5 JP WO2022006283 A5 JPWO2022006283 A5 JP WO2022006283A5 JP 2022581408 A JP2022581408 A JP 2022581408A JP 2022581408 A JP2022581408 A JP 2022581408A JP WO2022006283 A5 JPWO2022006283 A5 JP WO2022006283A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- administration
- pharmaceutical composition
- nmosd
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063046133P | 2020-06-30 | 2020-06-30 | |
| US63/046,133 | 2020-06-30 | ||
| US202063052093P | 2020-07-15 | 2020-07-15 | |
| US63/052,093 | 2020-07-15 | ||
| US202063071092P | 2020-08-27 | 2020-08-27 | |
| US63/071,092 | 2020-08-27 | ||
| PCT/US2021/039911 WO2022006283A2 (en) | 2020-06-30 | 2021-06-30 | Methods of treating neuromyelitis optica spectrum disorder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023534916A JP2023534916A (ja) | 2023-08-15 |
| JPWO2022006283A5 true JPWO2022006283A5 (enExample) | 2024-07-09 |
Family
ID=79321915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022581408A Pending JP2023534916A (ja) | 2020-06-30 | 2021-06-30 | 視神経脊髄炎スペクトラム障害を治療する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230406928A1 (enExample) |
| EP (1) | EP4172211A4 (enExample) |
| JP (1) | JP2023534916A (enExample) |
| KR (1) | KR20230030642A (enExample) |
| CN (1) | CN116234571A (enExample) |
| AU (1) | AU2021299307A1 (enExample) |
| BR (1) | BR112022026747A2 (enExample) |
| CA (1) | CA3178954A1 (enExample) |
| IL (1) | IL299381A (enExample) |
| MX (1) | MX2022016236A (enExample) |
| WO (1) | WO2022006283A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230097118A (ko) * | 2020-10-29 | 2023-06-30 | 비엘라 바이오, 인크. | 자가면역 질환을 치료하기 위한 항-cd19 항체의 사용 |
| CN117797245A (zh) * | 2023-12-29 | 2024-04-02 | 广州赛莱拉干细胞科技股份有限公司 | 人乳脂球表皮生长因子8用于制备治疗视神经脊髓炎谱系疾病药物中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021020924A2 (pt) * | 2019-04-24 | 2022-04-19 | Viela Bio Inc | Uso de um anticorpo anti-cd19 para tratar doença autoimune |
| KR20230097118A (ko) * | 2020-10-29 | 2023-06-30 | 비엘라 바이오, 인크. | 자가면역 질환을 치료하기 위한 항-cd19 항체의 사용 |
-
2021
- 2021-06-30 KR KR1020237002980A patent/KR20230030642A/ko active Pending
- 2021-06-30 EP EP21834411.7A patent/EP4172211A4/en active Pending
- 2021-06-30 CA CA3178954A patent/CA3178954A1/en active Pending
- 2021-06-30 JP JP2022581408A patent/JP2023534916A/ja active Pending
- 2021-06-30 AU AU2021299307A patent/AU2021299307A1/en active Pending
- 2021-06-30 MX MX2022016236A patent/MX2022016236A/es unknown
- 2021-06-30 IL IL299381A patent/IL299381A/en unknown
- 2021-06-30 CN CN202180046409.5A patent/CN116234571A/zh active Pending
- 2021-06-30 WO PCT/US2021/039911 patent/WO2022006283A2/en not_active Ceased
- 2021-06-30 BR BR112022026747A patent/BR112022026747A2/pt unknown
-
2022
- 2022-12-28 US US18/147,287 patent/US20230406928A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bachurin et al. | Mild cognitive impairment due to Alzheimer disease: Contemporary approaches to diagnostics and pharmacological intervention | |
| JP2025038127A (ja) | Ｉｌ－４ｒアンタゴニストを投与することにより喘息を処置又は予防するための方法 | |
| JP2023116770A5 (enExample) | ||
| Nasr et al. | ADEM: literature review and case report of acute psychosis presentation | |
| D'Amico et al. | Placing CD20-targeted B cell depletion in multiple sclerosis therapeutic scenario: Present and future perspectives | |
| JP2024112859A5 (enExample) | ||
| Ioannides et al. | Pemphigus | |
| JP7541505B2 (ja) | アルツハイマー病の治療及び予防方法 | |
| RU2006120950A (ru) | Антитело к cd40: препарат и способы | |
| CN114173819A (zh) | 通过施用il-4r拮抗剂治疗过敏和增强过敏原特异性免疫疗法的方法 | |
| JP2022033868A5 (enExample) | ||
| US20230303677A1 (en) | Methods of treating new-onset plaque type psoriasis using il-17 antagonists | |
| JP2019519584A (ja) | アミロイドーシスを処置するための組成物 | |
| CN114401742B (zh) | 通过转换疗法治疗rms | |
| JP7781519B2 (ja) | グルカゴン受容体シグナル伝達に干渉することによって尿素サイクル異常症を治療する方法 | |
| JP2022125248A (ja) | 視神経脊髄炎スペクトル障害の治療に有用な組成物及び方法 | |
| JPWO2022006283A5 (enExample) | ||
| Comi | Early treatment | |
| AU2020386061A1 (en) | Anti-alpha-synuclein monoclonal antibodies, and methods using same | |
| TW202120546A (zh) | 使用介白素-17（il-17）拮抗劑治療狼瘡性腎炎之方法 | |
| TW202430554A (zh) | 使用ｔａｕ ＰＥＴ水平之治療方法 | |
| JP2024535831A (ja) | 結節性痒疹の治療のためのｉｌ－１３阻害剤 | |
| JPWO2020010024A5 (enExample) | ||
| Golden | A Review of Multiple Sclerosis Treatments: Interferon Beta, Glatiramer Acetate, Fingolimod, and Natalizumab | |
| JP7029878B2 (ja) | 疾患および障害の治療方法および組成物 |